TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05633667 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT06316271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06460168 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04898634 — Predictive Biomarker (PRD): KLK2 mRNA
Genes: KLK2
Study NCT05029921 — Safety Biomarker (SAF): Interleukin 12
Study NCT06544616 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06392841 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study NCT06392841 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study NCT06392841 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT06392841 — Predictive Biomarker (PRD): RAD51B mRNA
Genes: RAD51B; RAD51L1; REC2
Study NCT06788691 — Surrogate Endpoint (SUR): Hematologic response
Study NCT06340360 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06730230 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06544954 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000790 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04967690 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT06659614 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06659614 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT06659614 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06659614 — Predictive Biomarker (PRD): HOXB13 mRNA
Genes: HOXB13
Study NCT06520345 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06098014 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06098014 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT04266275 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT06443034 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT05803941 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05613270 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT05613270 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06188702 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT06003179 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT04880811 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05704985 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05585502 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT05383820 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT06218602 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05144698 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05144698 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT05144698 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT05144698 — Predictive Biomarker (PRD): LAG3 mRNA
Genes: LAG3; FDC
Study NCT05144698 — Predictive Biomarker (PRD): LAIR1 mRNA
Genes: LAIR1; CD305
Study NCT04791384 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05325918 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06122584 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06338644 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06338644 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05334810 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06112925 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06059885 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05978453 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06553872 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05137054 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05008328 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05809583 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05912426 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05904093 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06660680 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT04395508 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04395508 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05447910 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05447910 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05447910 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05166499 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT05612880 — Predictive Biomarker (PRD): ARSI mRNA
Genes: ARSI
Study NCT05698186 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05698186 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05698186 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05923177 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05923177 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06547164 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06109181 — Predictive Biomarker (PRD): PKP2 mRNA
Genes: PKP2
Study NCT06119581 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05457257 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06659653 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06659653 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06660511 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06660511 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06660511 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06660511 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06319391 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT04933396 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT05670106 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05692804 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05692804 — Predictive Biomarker (PRD): ENO2 mRNA
Genes: ENO2
Study NCT05503953 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04849481 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04849481 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05797233 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05797233 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05797233 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05819398 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05437575 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT05953064 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06049667 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT06478251 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04966143 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05326412 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT00008866 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06210815 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06015659 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT00000841 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04722848 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05000684 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT05088460 — Predictive Biomarker (PRD): LEPROT mRNA
Genes: LEPROT; LEPR; OBR
Study NCT05088460 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05087303 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05675150 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06167460 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05515809 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05467943 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT06162572 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06162572 — Predictive Biomarker (PRD): KLRC1 mRNA
Genes: KLRC1; NKG2A
Study NCT05763511 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05170360 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05587296 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05587296 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06279897 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06116305 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05465135 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT06297603 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05182112 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05970172 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04717414 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04717414 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study NCT04833907 — Predictive Biomarker (PRD): ASPA mRNA
Genes: ASPA; ACY2; ASP
Study NCT05313646 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04960891 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05658445 — Predictive Biomarker (PRD): BIRC7 mRNA
Genes: BIRC7; KIAP; LIVIN; MLIAP; RNF50; UNQ5800/PRO19607/PRO21344
Study NCT06081829 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06413745 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06365359 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06365359 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05574907 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04856397 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04856397 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05805501 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04516681 — Predictive Biomarker (PRD): SLC2A3 mRNA
Genes: SLC2A3; GLUT3
Study NCT05976035 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05976035 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05347823 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06609109 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06662188 — Predictive Biomarker (PRD): SHANK3 mRNA
Genes: SHANK3; KIAA1650; PROSAP2; PSAP2
Study NCT04760691 — Predictive Biomarker (PRD): SRY mRNA
Genes: SRY; TDF
Study NCT06034743 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06616155 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT06616155 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT05330845 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05330845 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT06608511 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05204563 — Predictive Biomarker (PRD): REL mRNA
Genes: REL
Study NCT05641649 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT03086850 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03086850 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03086850 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06161974 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT06073756 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04999995 — Predictive Biomarker (PRD): UCHL1 mRNA
Genes: UCHL1
Study NCT05489679 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05489679 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05489679 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06381570 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06381570 — Predictive Biomarker (PRD): KIAA1549 mRNA
Genes: KIAA1549
Study NCT06483776 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study NCT04953286 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04699825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04170101 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05163054 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06762470 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06307600 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT06767150 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06527495 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06527495 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT06527495 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06391905 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT06242795 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT05959005 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06647888 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06765915 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT05086666 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT05703555 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06766435 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05393232 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06047158 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05154851 — Predictive Biomarker (PRD): LMNA mRNA
Genes: LMNA; LMN1
Study NCT06226896 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06730711 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05639946 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT06264661 — Predictive Biomarker (PRD): BMAL1 mRNA
Genes: BMAL1; ARNTL; BHLHE5; MOP3; PASD3
Study NCT06264661 — Predictive Biomarker (PRD): PER1 mRNA
Genes: PER1; KIAA0482; PER; RIGUI
Study NCT06264661 — Predictive Biomarker (PRD): PER2 mRNA
Genes: PER2; KIAA0347
Study NCT05958784 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05958784 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06171178 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06763640 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06767046 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06769971 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06769971 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06769971 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06769971 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT05077306 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06398106 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT06087263 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT06011486 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05835401 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06596304 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05848271 — Predictive Biomarker (PRD): HPDL mRNA
Genes: HPDL; GLOXD1
Study NCT04661813 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06315010 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06315010 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT05415579 — Predictive Biomarker (PRD): DDC mRNA
Genes: DDC; AADC
Study NCT04220203 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06487377 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04846556 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT06059937 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06150820 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT05290077 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT06207760 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06207760 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05559372 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06187506 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04764188 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06477016 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06031688 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04712175 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05897424 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT00189358 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00189358 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04902885 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT05791422 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study NCT05222802 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05222802 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06190314 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05076513 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT05076513 — Predictive Biomarker (PRD): ATRX mRNA
Genes: ATRX; RAD54L; XH2
Study NCT06180811 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06488950 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT04979637 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study NCT05351385 — Safety Biomarker (SAF): Vitamin K-dependent protein S
Genes: PROS1; PROS
Study NCT06000657 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06578559 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06578559 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06578559 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study NCT06578559 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT05429710 — Predictive Biomarker (PRD): SOX2 mRNA
Genes: SOX2
Study NCT05429710 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05704218 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT05936086 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05966818 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05162235 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT04895189 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05957536 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06577376 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06648889 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05071664 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06487949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05332262 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT06247826 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06189820 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT04970706 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04970706 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT04970706 — Safety Biomarker (SAF): Interleukin 1
Study NCT04970706 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT05596981 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05200767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05200767 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05555589 — Predictive Biomarker (PRD): RGN mRNA
Genes: RGN; SMP30
Study NCT06483672 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04808375 — Pharmacodynamic Biomarker (PDY): Blood coagulation